Longitudinal Prospective Study of Neurocognition & Neuroimaging in Primary BT Patients | MicrobiomeTrials← Back to trialsNCT05576103
Longitudinal Prospective Study of Neurocognition & Neuroimaging in Primary BT Patients
RecruitingOBSERVATIONAL
Trial Details
Start: 2015-01Est. Completion: 2030-12
Enrollment target: 300 participants Locations- Moores Cancer Center, San Diego, California, United States
ContactJona Hattangadi-Gluth, MD
Other microbiome trials you might be interested in
Disease/Condition Name Cancer-related Cognitive DysfunctionChronic Lymphocytic Leukemia (CLL)Chronic Myeloid Leukemia, BCR-ABL1 Positive
This study examines whether there are differences in brain health or well-being in patients receiving TKI therapy for le…
Rochester, United StatesEst. completion Feb 28, 2029
Lung CancerLung Cancer (NSCLC)Locally Advanced NSCLCMetastatic NSCLC - Non-Small Cell Lung Cancer
This clinical trial evaluates the combination of olomorasib and pembrolizumab as a first-line treatment for patients wit…
Chapel Hill, United States
Est. completion Jun 21, 2030
Rett Syndrome
Rett syndrome (RTT) is a rare genetic neurodevelopmental disorder caused primarily by mutations in the MECP2 gene, leadi…
Fortaleza, BrazilCompleted Jun 2027